Allergy experts weigh ruxolitinib, tapinarof, and roflumilast—new nonsteroidal creams that reshape atopic dermatitis care beyond steroids.
Reassessing Topical Approaches in Atopic Dermatitis: Risks, Benefits, and New Options in 2026
Advertisement
Advertisement
Trending on HCPLive
1
Diagnostic Pearls and New Therapies in Connective Tissue Disease, With Michelle Min, MD
2
Rethinking “Type 2”: Inside the 2026 AACE Diabetes Classification Algorithm
3
VIASKIN Peanut Patch Efficacy Holds in Kids With Atopic Comorbidities
4
Fezolinetant Shows No CNS Safety Signal in Pooled Analysis of 3100 Women, With Marla Shapiro, CM
5